Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduning Injection vs Oseltamivir for Influenza High Fever
CTR20140794Phase 3Active
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Jan 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Reduning in influenza, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Jan 2015; status: active.
02
Drugs
Reduning
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20140794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140794.